Diazepam Nasal Spray (Valtoco®) UpdatesEarlier this year, Valtoco (diazepam nasal spray) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizure clusters and acute repetitive seizures. The makers of Valtoco have recently announced that it will now be available in pharmacies nationwide. Read the full press release from Neurelis, Inc. here.Valtoco is currently approved for adult and pediatric patients six years of age and older. If you have questions about this medicine, please email info@neurelis.com
SOAR Webinar
**At this time, the SOAR study has reached capacity for conference participation. However, there still may be opportunities for research participation at the family conference due to cancellations or addition of other opportunities. If you would like to be placed on a...